Literature DB >> 8064239

Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.

Y Ichiyoshi1, P Casali.   

Abstract

Polyreactive antibodies (Abs) constitute a major proportion of the early Ab repertoire and are an important component of the natural defense mechanisms against infections. They are primarily immunoglobulin M (IgM) and bind a variety of structurally dissimilar self and exogenous antigens (Ags) with moderate affinity. We analyzed the contribution of Ig polyvalency and of heavy (H) and light (L) chain variable (V) regions to polyreactivity in recombinatorial experiments involving the VH-diversity(D)-JH and V kappa-J kappa gene segments of a human polyreactive IgM, monoclonal antibody 55 (mAb55), and those of a human monoreactive anti-insulin IgG, mAb13, in an in vitro C gamma l and C kappa human expression system. These mAbs are virtually identical in their VH and V kappa gene segment sequences. First, we expressed the VH-D-JH and V kappa-J kappa genes of the IgM mAb55 as V segments of an IgG molecule. The bivalent recombinant IgG Ab bound multiple Ags with an efficiency only slightly lower than that of the original decavalent IgM mAb55, suggesting that class switch to IgG does not affect the Ig polyreactivity. Second, we coexpressed the mAb55-derived H or kappa chain with the mAb13-derived kappa or H chain, respectively. The hybrid IgG Ab bearing the mAb55-derived H chain V segment paired with the mAb13-derived kappa V segment, but not that bearing the mAb13-derived H chain V segment paired with the mAb55-derived kappa V segment, bound multiple Ags, suggesting that the Ig H chain plays a major role in the Ig polyreactivity. Third, we shuffled the framework 1 (FR1)-FR3 and complementarity determining region 3 (CDR3) regions of the H and kappa chain V segments of the mAB55-derived IgG molecule with the corresponding regions of the monoreactive IgG mAb13. The mAb55-derived IgG molecule lost polyreactivity when the H chain CDR3, but not the FR1-FR3 region, was replaced by the corresponding region of mAb13, suggesting that within the H chain, the CDR3 provides the major structural correlate for multiple Ag-binding. This was formally proved by the multiple Ag-binding of the originally monoreactive mAb13-derived IgG molecule grafted with the mAb55-derived H chain CDR3. The polyreactivity of this chimeric IgG was maximized by grafting of the mAb55-derived kappa chain FR1-FR3, but not that of the kappa chain CDR3.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064239      PMCID: PMC2191637          DOI: 10.1084/jem.180.3.885

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  49 in total

1.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

2.  Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.

Authors:  E A Kabat; T T Wu
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

3.  Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions.

Authors:  I Sanz
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

4.  Chimeric antibodies with anti-dextran-derived complementarity-determining regions and anti-p-azophenylarsonate-derived framework regions.

Authors:  C Y Kao; J Sharon
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

5.  Lack of promiscuity in autoantigen-specific H and L chain combinations as revealed by human H and L chain "roulette".

Authors:  S Portolano; G D Chazenbalk; J S Hutchison; S M McLachlan; B Rapoport
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

6.  Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation.

Authors:  H Ikematsu; N Harindranath; Y Ueki; A L Notkins; P Casali
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

7.  Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient.

Authors:  N Harindranath; I S Goldfarb; H Ikematsu; S E Burastero; R L Wilder; A L Notkins; P Casali
Journal:  Int Immunol       Date:  1991-09       Impact factor: 4.823

8.  Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors.

Authors:  L Mantovani; R L Wilder; P Casali
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

9.  Naturally occurring antibodies devoid of light chains.

Authors:  C Hamers-Casterman; T Atarhouch; S Muyldermans; G Robinson; C Hamers; E B Songa; N Bendahman; R Hamers
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

10.  Evidence for somatic selection of natural autoantibodies.

Authors:  T Martin; S F Duffy; D A Carson; T J Kipps
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  54 in total

1.  Molecular structure of eight human autoreactive monoclonal antibodies.

Authors:  I Aguilera; J Melero; A Nuñez-Roldan; B Sanchez
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

2.  Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.

Authors:  H Zan; A Cerutti; P Dramitinos; A Schaffer; Z Li; P Casali
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

3.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

Review 4.  Polyreactive antibodies in adaptive immune responses to viruses.

Authors:  Hugo Mouquet; Michel C Nussenzweig
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

5.  Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies.

Authors:  D Tarrago; I Aguilera; J Melero; I Wichmann; A Nuñez-Roldan; B Sanchez
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

6.  Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire.

Authors:  Bryan S Briney; Jordan R Willis; Mark D Hicar; James W Thomas; James E Crowe
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 7.  Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Authors:  Joel Finney; Akiko Watanabe; Garnett Kelsoe; Masayuki Kuraoka
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

8.  VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection.

Authors:  E W Schettino; S K Chai; M T Kasaian; H W Schroeder; P Casali
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

9.  Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells.

Authors:  Nai-Ying Zheng; Kenneth Wilson; Xiaojian Wang; Angela Boston; Grant Kolar; Stephen M Jackson; Yong-Jun Liu; Virginia Pascual; J Donald Capra; Patrick C Wilson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance.

Authors:  Laurent Verkoczy; Marilyn Diaz; T Matt Holl; Ying-Bin Ouyang; Hilary Bouton-Verville; S Munir Alam; Hua-Xin Liao; Garnett Kelsoe; Barton F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.